Abstract:Gasdermin E (GSDME) has recently been identified as a critical executioner to mediate pyroptosis. While epidermal keratinocytes can initiate GSDME-mediated pyroptosis, the role of keratinocyte GSDME in psoriatic dermatitis remains poorly characterized. Through analysis of GEO datasets, we found elevated GSDME levels in psoriatic lesional skin. Additionally, GSDME levels correlated with both psoriasis severity and response to biologics treatments. Single-cell RNA sequencing (scRNA-seq) from a GEO dataset revealed GSDME upregulation in keratinocytes of psoriasis patients. In the imiquimod (IMQ)-induced psoriasis-like dermatitis mouse model, both full-length and cleaved forms of caspase-3 and GSDME were elevated in the epidermis. Abnormal proliferation and differentiation of keratinocytes and dermatitis were attenuated in Gsdme -/- mice and keratinocyte-specific Gsdme conditional knockout mice after IMQ stimulation. Exposure of keratinocytes to mixed cytokines (M5), mimicking psoriatic conditions, led to GSDME cleavage. Moreover, the interaction between GSDME-FL and p65 or c-jun was significantly increased after M5 stimulation. GSDME knockdown inhibited nuclear translocation of p65 and c-jun and decreased upregulation of psoriatic inflammatory mediators such as IL1β, CCL20, CXCL1, CXCL8, S100A8, and S100A9 in M5-challenged keratinocytes. In conclusion, GSDME in keratinocytes contributes to the pathogenesis and progression of psoriasis, potentially in a pyroptosis-independent manner by interacting and promoting translocation of p65 and c-jun. These findings suggest that keratinocyte GSDME could serve as a potential therapeutic target for psoriasis treatment.

What problem does this paper attempt to address?

The paper primarily explores the role of Gasdermin E (GSDME) in the pathogenesis of psoriasis. The study found that the expression level of GSDME is elevated in the lesional skin of psoriasis patients and is associated with the severity of the disease and the response to biologic treatments. Specifically, the paper addresses the following key issues: 1. **Correlation between GSDME and psoriasis**: By analyzing multiple gene expression databases (such as the GEO dataset), researchers found that GSDME is upregulated in the lesional skin of psoriasis patients, while it is lower in non-lesional skin or healthy controls. 2. **Role of GSDME in a mouse model of psoriasis**: Using an Imiquimod (IMQ)-induced mouse model of psoriasis-like dermatitis, researchers observed increased expression of GSDME and its activated form (N-terminal fragment) in epidermal cells. Additionally, GSDME knockout (Gsdme-/-) mice and epidermal cell-specific GSDME conditional knockout (cKO) mice showed reduced abnormal proliferation and differentiation, and improved dermatitis symptoms after IMQ stimulation. 3. **Functional mechanism of GSDME in epidermal cells**: Through in vitro experiments, using a mixture of cytokines (M5) to treat the human immortalized keratinocyte cell line HaCaT to simulate the psoriasis environment, the study found that GSDME can promote the translocation of p65 and c-jun to the nucleus, thereby regulating the expression of various inflammatory mediators (such as IL-1β, CCL20, CXCL1, CXCL8, S100A8, and S100A9). In summary, this paper reveals the important role of GSDME in the pathogenesis of psoriasis, particularly in regulating the inflammatory response of epidermal cells, suggesting that GSDME may become a new target for the treatment of psoriasis.

Gasdermin E promotes translocation of p65 and c-jun into nucleus in keratinocytes for progression of psoriatic skin inflammation